...
首页> 外文期刊>Journal of biomaterials applications >Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or dithioerythritol as chain extenders
【24h】

Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or dithioerythritol as chain extenders

机译:以4,4'-亚甲基双(环己基异氰酸酯),聚己内酯二醇和丁二醇或二硫赤藓糖醇为增链剂制备的可生物降解的分段聚氨酯的血小板粘附性和人脐静脉内皮细胞的细胞相容性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex? although an early stage of activation was observed on biodegradable segmented polyurethane prepared with dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex? medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.
机译:使用聚己内酯二醇作为软链段,4,4'-亚甲基双(环己基异氰酸酯)(HMDI)和丁二醇或二硫赤藓糖醇作为扩链剂,制备可生物降解的分段聚氨酯。在研究的所有分段聚氨酯中血小板粘附性均相似,与Tecoflex®没有区别。尽管在用二硫赤藓糖醇制备的可生物降解的分段聚氨酯中观察到了活化的早期阶段。在1、2和7天后,与可生物降解的分段聚氨酯提取物接触的人脐静脉内皮细胞的相对活力高于80%。此外,两种可生物降解的分段聚氨酯材料都支持人脐静脉内皮细胞的粘附,扩散和生存能力,类似于Tecoflex®。医用级聚氨酯。这些可生物降解的分段聚氨酯代表了有前途的心血管应用材料。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号